Torsten Hechler

Years Active: 2020-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Yujing Li, Yifan Sun, Michael Kulke, Torsten Hechler, Kevin Van der Jeught, Tianhan Dong, Bin He, Kathy D Miller, Milan Radovich, Bryan P Schneider, Andreas Pahl, Xinna Zhang, Xiongbin Lu
Targeted immunotherapy for HER2-low breast cancer with 17p loss. Science translational medicine 13 (580) (2021)
Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, Anja Baumann, Nicola Giesen, Anikó Pálfi, Christoph Müller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Müller-Tidow, Alwin Krämer, Hartmut Goldschmidt, Andreas Pahl, Marc S Raab
HDP-101, an Anti-BCMA Antibody-Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells. Molecular cancer therapeutics 20 (2) (2020)

Torsten Hechler.css-eqlu8i{font-size:small;padding-left:4px;}